#### **Exhibit 31.2**

#### ** **

#### **CERTIFICATION OFCHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THESECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THESARBANES-OXLEY ACT OF 2002**

#### ** **

I, John M. Hanson, certify that:

 

1.               I have reviewed this quarterly report on Form 10-Qof Talecris Biotherapeutics Holdings Corp.;

 

2.               Based on my knowledge, this report does not containany untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

 

3.               Based on my knowledge, the financial statements, andother financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations, and cashflows of the registrant as of, and for, the periods presented in this report;

 

4.               The registrant’s other certifying officer(s) andI are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))for the registrant and have:

 

a.               Designed such disclosure controls and procedures, orcaused such disclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;

 

b.              [paragraph omitted in accordance with Exchange Act Rule 13a-14(a)]

 

c.               Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, as of theend of the period covered by this report based on such evaluation; and

 

d.              Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during the registrant’smost recent fiscal quarter (the registrant’s fourth fiscal quarter in the caseof an annual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting;and

 

5.               The registrant’s other certifying officer(s) and Ihave disclosed, based on our most recent evaluation of internal control overfinancial reporting, to the registrant’s auditors and the audit committee ofthe registrant’s board of directors (or persons performing the equivalentfunctions):

 

a.               All significant deficiencies and material weaknessesin the design or operation of internal control over financial reporting whichare reasonably likely to adversely affect the registrant’s ability to record,process, summarize, and report financial information; and

 

b.              Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the registrant’sinternal control over financial reporting.

 

 
|   | Dated: November 9, 2009                              |
|--------|------------------------------------------------------|
|   |                                                 |
|   | /s/ John M. Hanson                                   |
|   | John M. Hanson                                       |
|   | Executive Vice President and Chief Financial Officer |

 

1

----